Abstract:Randomized controlled trials (RCTs) are the accepted standard for treatment effect estimation but they can be infeasible due to ethical reasons and prohibitive costs. Single-arm trials, where all patients belong to the treatment group, can be a viable alternative but require access to an external control group. We propose an identifiable deep latent-variable model for this scenario that can also account for missing covariate observations by modeling their structured missingness patterns. Our method uses amortized variational inference to learn both group-specific and identifiable shared latent representations, which can subsequently be used for {\em (i)} patient matching if treatment outcomes are not available for the treatment group, or for {\em (ii)} direct treatment effect estimation assuming outcomes are available for both groups. We evaluate the model on a public benchmark as well as on a data set consisting of a published RCT study and real-world electronic health records. Compared to previous methods, our results show improved performance both for direct treatment effect estimation as well as for effect estimation via patient matching.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to estimate treatment effects in single - arm trials. Specifically, the paper proposes an identifiable deep latent - variable model for estimating treatment effects through external control data when there is only treatment - group data and no control - group data. This method can handle the problem of missing covariate observations and can improve the accuracy of estimation by modeling these missing patterns. ### Main Problems and Challenges 1. **Data Limitations in Single - Arm Trials**: - In single - arm trials, all patients belong to the treatment group, lacking control - group data, which makes it difficult to directly estimate treatment effects. - It is necessary to obtain control - group data from external sources, such as electronic health records (EHR) in historical randomized controlled trials (RCTs) or real - world data (RWD). 2. **Differences in Covariate Distributions**: - There are differences in the covariate distributions between RCT data and RWD data, resulting in limited overlap between the two datasets, and methods are required to overcome this problem to provide reliable treatment effect estimates. 3. **Handling of Missing Data**: - Real - world data usually contains missing measurement values, and these missing patterns are non - random, requiring appropriate modeling and handling. ### Solutions The paper proposes a latent - variable model, which solves the above problems in the following ways: 1. **Latent - Variable Model**: - Use variational inference to learn group - specific and identifiable shared latent representations. - The model can explain the unique characteristics specific to the treatment group and the control group, while providing a compressed latent space for treatment effect estimation and patient matching. 2. **Handling Missing Data**: - Introduce an additional latent variable \( u \) to explain group - specific features, allowing \( z \) to be predictive but still guided by the reconstruction task. - Handle the problem of missing covariate observations by modeling the non - random structure of the missing patterns. 3. **Patient Matching**: - Perform patient matching in the low - dimensional latent space and select a subset of control - group patients that are most similar to the treatment - group patients. - Provide multiple matching strategies, including direct matching based on posterior means and matching based on full variational posteriors. ### Contributions 1. **A Principled Method for Handling Tasks**: - Propose a latent - variable model using variational inference, with identifiability guarantees, capable of inferring a predictive latent space between different covariate distributions and simultaneously modeling structured missing patterns. 2. **Extensive Ablation Studies**: - Demonstrate the competitiveness of the method in different scenarios through multiple semi - synthetic benchmarks and a large real - world dataset, including cases when both groups have outcome information and when only the control group has outcome information. ### Conclusion This paper effectively addresses the challenges of estimating treatment effects in single - arm trials by proposing a new latent - variable model, especially performing well in handling missing data and differences in covariate distributions. This method provides a more reliable and accurate means of estimating treatment effects for single - arm trials.

Estimating treatment effects from single-arm trials via latent-variable modeling

Causal Effect Estimation using identifiable Variational AutoEncoder with Latent Confounders and Post-Treatment Variables

Subgroup identification in clinical trials: an overview of available methods and their implementations with R

Estimating individual treatment effect: generalization bounds and algorithms

Learning Representations of Instruments for Partial Identification of Treatment Effects

Latent-state models for precision medicine

Robust estimation of heterogeneous treatment effects using electronic health record data

Empirical Likelihood-Based Estimation and Inference in Randomized Controlled Trials with High-Dimensional Covariates

ASSESSING THE TREATMENT EFFECT HETEROGENEITY WITH A LATENT VARIABLE

Variational Temporal Deconfounder for Individualized Treatment Effect Estimation from Longitudinal Observational Data

Estimating the Individual Treatment Effect with Different Treatment Group Sizes

Estimating Individual Causal Treatment Effect by Variable Decomposition

Regression-based multiple treatment effect estimation under covariate-adaptive randomization

High-dimensional model-assisted inference for treatment effects with multi-valued treatments

Identifying sparse treatment effects in high-dimensional outcome spaces

Within-Person Variability Score-Based Causal Inference: A Two-Step Estimation for Joint Effects of Time-Varying Treatments

Estimating Heterogeneous Treatment Effects by Combining Weak Instruments and Observational Data

Program Evaluation and Causal Inference with High-Dimensional Data

Identifying Effect Modification of Latent Population Characteristics on Risk Factors with a Sparse Varying Coefficient Regression

Generalized Linear Latent Variable Modeling for Multi-Group Studies

Stein-like estimators for causal mediation analysis in randomized trials